相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The influence of receptor expression and clinical subtypes on baseline [18F]FDG uptake in breast cancer: systematic review and meta-analysis
Cornelis M. de Mooij et al.
EJNMMI RESEARCH (2023)
Head-to-Head Comparison between 18F-FES PET/CT and 18F-FDG PET/CT in Oestrogen Receptor-Positive Breast Cancer: A Systematic Review and Meta-Analysis
Arnoldo Piccardo et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Head-to-Head Evaluation of 18F-FES and 18F-FDG PET/CT in Metastatic Invasive Lobular Breast Cancer
Gary A. Ulaner et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
Comparison of diagnostic sensitivity of [18F]fluoroestradiol and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for breast cancer recurrence in patients with a history of estrogen receptor-positive primary breast cancer
Sun Young Chae et al.
EJNMMI RESEARCH (2020)
Whole-Body Characterization of Estrogen Receptor Status in Metastatic Breast Cancer with 16α-18F-Fluoro-17β-Estradiol Positron Emission Tomography: Meta-Analysis and Recommendations for Integration into Clinical Applications
Brenda F. Kurland et al.
ONCOLOGIST (2020)
Diagnostic accuracy and safety of 16α-[18F]fluoro-17β-oestradiol PET-CT for the assessment of oestrogen receptor status in recurrent or metastatic lesions in patients with breast cancer: a prospective cohort study
Sun Young Chae et al.
LANCET ONCOLOGY (2019)
18F-FES PET/CT Influences the Staging and Management of Patients with Newly Diagnosed Estrogen Receptor-Positive Breast Cancer: A Retrospective Comparative Study with 18F-FDG PET/CT
Cheng Liu et al.
ONCOLOGIST (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
A high level of estrogen-stimulated proteins selects breast cancer patients treated with adjuvant endocrine therapy with good prognosis
Katrine L. H. Weischenfeldt et al.
ACTA ONCOLOGICA (2017)
Tumor Heterogeneity in Breast Cancer
Gulisa Turashvili et al.
FRONTIERS IN MEDICINE (2017)
Clinical Significance of 18F-FDG-PET in Invasive Lobular Carcinoma
Takaaki Fujii et al.
ANTICANCER RESEARCH (2016)
Recommendations and Technical Aspects of 16a-[18F]Fluoro-17β-Estradiol PET to Image the Estrogen Receptor In Vivo The Groningen Experience
Clasina M. Venema et al.
CLINICAL NUCLEAR MEDICINE (2016)
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Ronald Boellaard et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Increased 18F-fluoroestradiol uptake in radiation pneumonia
Zhongyi Yang et al.
ANNALS OF NUCLEAR MEDICINE (2013)
Can Fluorine-18 Fluoroestradiol Positron Emission Tomography-Computed Tomography Demonstrate the Heterogeneity of Breast Cancer In Vivo?
Zhongyi Yang et al.
CLINICAL BREAST CANCER (2013)
Heterogeneity of Estrogen Receptor Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients
Anna Babayan et al.
PLOS ONE (2013)
Factors influencing the uptake of 18F-fluoroestradiol in patients with estrogen receptor positive breast cancer
Lanell M. Peterson et al.
NUCLEAR MEDICINE AND BIOLOGY (2011)
ONCOPOOL - A European database for 16,944 cases of breast cancer
R. W. Blamey et al.
EUROPEAN JOURNAL OF CANCER (2010)
Degree of Tumor FDG Uptake Correlates with Proliferation Index in Triple Negative Breast Cancer
Julia Tchou et al.
MOLECULAR IMAGING AND BIOLOGY (2010)
False-Negative and False-Positive Results in FDG-PET and PET/CT in Breast Cancer
Rakesh Kumar et al.
PET CLINICS (2009)
Quantitative imaging of estrogen receptor expression in breast cancer with PET and 18F-fluoroestradiol
Lanell M. Peterson et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
分享论文
